Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03017170 · ClinicalTrials.gov registry record · Phase 1
Evaluation of the Effect of Dried Cranberry Powder in Women With Dry OAB
A Phase 1 study of Overactive Bladder, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- Phase 1
- Development phase
- 77
- Enrollment target
- 1
- Study location
NCT03017170: Completed Phase 1 study of Overactive Bladder, sponsored by Weill Medical College of Cornell University.
NCT03017170 is a Phase 1 study of Overactive Bladder that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 77 participants, below the 206-participant average among 46 other Overactive Bladder trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03017170, a Phase 1 study of Overactive Bladder, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 77 participants
- Enrollment target
- 1
- Study location
Study Summary
A randomized, double-blind, placebo controlled study to evaluate the efficacy of dried cranberry at 500 mg daily in women with overactive bladder for 6-months.
Conditions Studied
Interventions
- DRUG Placebo Oral Capsule
- DRUG Dried Cranberry
Study Locations (1)
New York
- Weill Cornell Medical College - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2016-04 |
| Est. Completion | 2018-07 |
| Phase | Phase 1 |
What the finished NCT03017170 record still lists
NCT03017170 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 77 participants, a relatively small participant target, below the 206-participant average among 46 other Overactive Bladder trials with a reported enrollment target (63% lower).
The record links to 1 condition, with Overactive Bladder appearing as the primary indexed condition, and to 2 interventions - of which Placebo Oral Capsule is the first listed.
NCT03017170 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03017170 about?
NCT03017170 is a clinical study titled "Evaluation of the Effect of Dried Cranberry Powder in Women With Dry OAB". A randomized, double-blind, placebo controlled study to evaluate the efficacy of dried cranberry at 500 mg daily in women with overactive bladder for 6-months.
What is the current status of trial NCT03017170?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 77 participants. The study started on 2016-04. Estimated completion is 2018-07.
What conditions does trial NCT03017170 study?
This clinical trial studies the following conditions: Overactive Bladder.
What interventions are being tested in trial NCT03017170?
The interventions under investigation include: Placebo Oral Capsule (DRUG), Dried Cranberry (DRUG).
Who is sponsoring clinical trial NCT03017170?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03017170 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Overactive Bladder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03017170's enrollment target sits among peer trials
77 28th of 46 higher than 18 of 46 other Overactive Bladder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Overactive Bladder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reduced-dose Botox for Urgency Incontinence Among Elder Females
ACTIVE NOT RECRUITING · Phase 1
-
A Study To Test The Interaction of Two Medications for Treatment of Overactive Bladder
COMPLETED · Phase 1
-
Botulin-A Toxin Instillations and Overactive Bladder
COMPLETED · Phase 1
-
A Two-Part Study to Determine: Best Medication Formulation and Food Effect
COMPLETED · Phase 1
-
Home Versus Office Removal of Percutaneous Nerve Evaluation (PNE) Lead
RECRUITING · NA
-
Bladder Botox UTI Antibiotic Prophylaxis
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02127398 · 77 participants · Phase 2
Stool Transplants to Treat Refractory Clostridium Difficile Colitis
- NCT04159103 · 77 participants · Phase 1
Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia
- NCT04683003 · 77 participants · Phase 3
A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura
- NCT05004116 · 77 participants · Phase 1
A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia